TY - JOUR AU - Llovet, J. AU - Zucman-Rossi, J. AU - Pikarsky, E. AU - Sangro, B. AU - Schwartz, M. AU - Sherman, M. PY - 2016 DA - 2016// TI - Hepatocellular carcinoma JO - Nat Rev Dis Primers VL - 2 UR - https://doi.org/10.1038/nrdp.2016.18 DO - 10.1038/nrdp.2016.18 ID - Llovet2016 ER - TY - JOUR AU - Park, J. W. AU - Chen, M. AU - Colombo, M. AU - Roberts, L. R. AU - Schwartz, M. AU - Chen, P. J. PY - 2015 DA - 2015// TI - Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study JO - Liver Int VL - 35 UR - https://doi.org/10.1111/liv.12818 DO - 10.1111/liv.12818 ID - Park2015 ER - TY - STD TI - World Health Organization. Cancer country profiles. Indonesia national incidence estimates and modelled survival. 2014. Available from: http://www.who.int/cancer/country-profiles/idn_en.pdf. (cited 29 April 2018). UR - http://www.who.int/cancer/country-profiles/idn_en.pdf ID - ref3 ER - TY - BOOK AU - Mulyana, E. PY - 2001 DA - 2001// TI - Analisis Kesintasan Pasien Hepatoma di RSUPN-CM Jakarta. [Tesis] PB - Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia CY - Jakarta ID - Mulyana2001 ER - TY - JOUR AU - El-Serag, H. B. AU - Marrero, J. A. AU - Rudolph, L. AU - Reddy, K. R. PY - 2008 DA - 2008// TI - Diagnosis and treatment of hepatocellular carcinoma JO - Gastroenterology VL - 134 UR - https://doi.org/10.1053/j.gastro.2008.02.090 DO - 10.1053/j.gastro.2008.02.090 ID - El-Serag2008 ER - TY - STD TI - Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, at al. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int 2012;32:1053–1063. ID - ref6 ER - TY - BOOK AU - Lesmana, L. A. AU - Waspodo, A. S. AU - Gani, R. A. AU - Hasan, I. AU - Siregar, L. AU - Sulaiman, A. S. PY - 2017 DA - 2017// TI - Konsensus Nasional Penatalaksanaan Karsinoma Sel Hati PB - Perhimpunan Peneliti Hati Indonesia CY - Jakarta ID - Lesmana2017 ER - TY - JOUR AU - Asrih, M. AU - Lenglet, S. AU - Mach, F. AU - Montecucco, F. PY - 2013 DA - 2013// TI - Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma JO - World J Gastroenterol: WJG VL - 19 UR - https://doi.org/10.3748/wjg.v19.i3.328 DO - 10.3748/wjg.v19.i3.328 ID - Asrih2013 ER - TY - JOUR AU - Song, P. P. AU - Xia, J. F. AU - Inagaki, Y. AU - Hasegawa, K. AU - Sakamoto, Y. AU - Kokudo, N. AU - Tang, W. PY - 2016 DA - 2016// TI - Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma JO - World J Gastroenterol VL - 22 UR - https://doi.org/10.3748/wjg.v22.i1.262 DO - 10.3748/wjg.v22.i1.262 ID - Song2016 ER - TY - JOUR AU - Bertino, G. AU - Neri, S. AU - Bruno, C. M. AU - Ardiri, A. M. AU - Calvagno, G. S. AU - Malaguarnera, M. PY - 2011 DA - 2011// TI - Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma JO - Minerva Med VL - 102 ID - Bertino2011 ER - TY - JOUR AU - Gopal, P. AU - Yopp, A. C. AU - Waljee, A. K. AU - Chiang, J. AU - Nehra, M. AU - Kandunoori, P. PY - 2014 DA - 2014// TI - Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis JO - Clin Gastroenterol Hepatol VL - 12 UR - https://doi.org/10.1016/j.cgh.2013.09.053 DO - 10.1016/j.cgh.2013.09.053 ID - Gopal2014 ER - TY - JOUR AU - Carlo, I. AU - Mannino, M. AU - Toro, A. AU - Ardiri, A. AU - Galia, A. AU - Cappello, G. PY - 2012 DA - 2012// TI - Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature JO - World J Surg Oncol VL - 10 UR - https://doi.org/10.1186/1477-7819-10-79 DO - 10.1186/1477-7819-10-79 ID - Carlo2012 ER - TY - JOUR AU - Bruix, J. AU - Sherman, M. PY - 2011 DA - 2011// TI - Management of hepatocellular carcinoma: an update JO - Hepatology VL - 53 UR - https://doi.org/10.1002/hep.24199 DO - 10.1002/hep.24199 ID - Bruix2011 ER - TY - JOUR PY - 2012 DA - 2012// TI - EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma JO - J Hepatol VL - 56 UR - https://doi.org/10.1016/j.jhep.2011.12.001 DO - 10.1016/j.jhep.2011.12.001 ID - ref14 ER - TY - JOUR AU - Omata, M. AU - Lesmana, L. A. AU - Tateishi, R. AU - Chen, P. J. AU - Lin, S. M. AU - Yoshida, H. PY - 2010 DA - 2010// TI - Asian Pacific Association for the Study of the liver consensus recommendations on hepatocellular carcinoma JO - Hepatol Int VL - 4 UR - https://doi.org/10.1007/s12072-010-9165-7 DO - 10.1007/s12072-010-9165-7 ID - Omata2010 ER - TY - JOUR AU - Xie, D. Y. AU - Ren, Z. G. AU - Zhou, J. AU - Fan, J. AU - Gao, Q. PY - 2017 DA - 2017// TI - Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma JO - Hepatobiliary Surg Nutr VL - 6 UR - https://doi.org/10.21037/hbsn.2017.11.01 DO - 10.21037/hbsn.2017.11.01 ID - Xie2017 ER - TY - STD TI - Kokudo N, Hasegawa K, Akahane M, Igaki H, Izumi N, Ichida T, et al. Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC guidelines). Hepatol Res. 2015;45. ID - ref17 ER - TY - JOUR AU - Trevisani, F. AU - D'Intino, P. E. AU - Morselli-Labate, A. M. PY - 2001 DA - 2001// TI - Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status JO - J Hepatol VL - 34 UR - https://doi.org/10.1016/S0168-8278(00)00053-2 DO - 10.1016/S0168-8278(00)00053-2 ID - Trevisani2001 ER - TY - JOUR AU - Chan, S. L. AU - Mo, F. AU - Johnson, P. J. AU - Siu, D. Y. AU - Chan, M. H. AU - Lau, W. Y. PY - 2014 DA - 2014// TI - Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass JO - HPB VL - 16 UR - https://doi.org/10.1111/hpb.12146 DO - 10.1111/hpb.12146 ID - Chan2014 ER - TY - JOUR AU - Biselli, M. AU - Conti, F. AU - Gramenzi, A. AU - Frigerio, M. AU - Cucchetti, A. AU - Fatti, G. PY - 2015 DA - 2015// TI - A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2014.536 DO - 10.1038/bjc.2014.536 ID - Biselli2015 ER - TY - JOUR AU - Kew, M. C. PY - 2012 DA - 2012// TI - Hepatocellular carcinoma in developing countries: prevention, diagnosis and treatment JO - World J Hepatol VL - 4 UR - https://doi.org/10.4254/wjh.v4.i3.99 DO - 10.4254/wjh.v4.i3.99 ID - Kew2012 ER - TY - JOUR AU - Gust, I. D. PY - 1996 DA - 1996// TI - Epidemiology of hepatitis B infection in the Western Pacific and South East Asia JO - Gut VL - 38 UR - https://doi.org/10.1136/gut.38.Suppl_2.S18 DO - 10.1136/gut.38.Suppl_2.S18 ID - Gust1996 ER - TY - JOUR AU - Murugavel, K. G. AU - Mathews, S. AU - Jayanthi, V. AU - Shankar, E. M. AU - Hari, R. AU - Surendran, R. PY - 2008 DA - 2008// TI - Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies JO - Int J Infect Dis VL - 12 UR - https://doi.org/10.1016/j.ijid.2008.04.010 DO - 10.1016/j.ijid.2008.04.010 ID - Murugavel2008 ER - TY - JOUR AU - Liu, C. AU - Xiao, G. Q. AU - Yan, L. N. AU - Li, B. AU - Jiang, L. AU - Wen, T. F. PY - 2013 DA - 2013// TI - Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma JO - World J Gastroenterol: WJG VL - 19 UR - https://doi.org/10.3748/wjg.v19.i11.1811 DO - 10.3748/wjg.v19.i11.1811 ID - Liu2013 ER - TY - JOUR AU - Hann, H. W. AU - Fu, X. AU - Myers, R. E. AU - Hann, R. S. AU - Wan, S. AU - Kim, S. H. PY - 2012 DA - 2012// TI - Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection–results from a clinic-based longitudinal cohort JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.02.065 DO - 10.1016/j.ejca.2012.02.065 ID - Hann2012 ER - TY - JOUR AU - Li, M. AU - Zhu, M. AU - Li, W. AU - Lu, Y. AU - Xie, X. AU - Wu, Y. PY - 2013 DA - 2013// TI - Alpha-fetoprotein receptor as an early indicator of HBxdriven hepatocarcinogenesis and its applications in tracing cancer cell metastasis JO - Cancer Lett VL - 330 UR - https://doi.org/10.1016/j.canlet.2012.11.042 DO - 10.1016/j.canlet.2012.11.042 ID - Li2013 ER - TY - JOUR AU - Zhang, C. AU - Chen, X. AU - Liu, H. AU - Li, H. AU - Jiang, W. AU - Hou, W. PY - 2015 DA - 2015// TI - Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29548 DO - 10.1002/ijc.29548 ID - Zhang2015 ER - TY - JOUR AU - Yao, M. AU - Zhao, J. AU - Lu, F. PY - 2016 DA - 2016// TI - Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.6913 DO - 10.18632/oncotarget.6913 ID - Yao2016 ER - TY - JOUR AU - Furui, J. AU - Furukawa, M. AU - Kanematsu, T. PY - 1995 DA - 1995// TI - The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma JO - Hepatogastroenterology VL - 42 ID - Furui1995 ER - TY - JOUR AU - Peng, Y. C. AU - Chan, C. S. AU - Chen, G. H. PY - 1999 DA - 1999// TI - The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma JO - Hepato-gastroenterology VL - 46 ID - Peng1999 ER - TY - JOUR AU - Kobeisy, M. A. AU - Morsy, K. H. AU - Galal, M. AU - Sayed, S. K. AU - Ashmawy, M. M. AU - Mohammad, F. M. PY - 2012 DA - 2012// TI - Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT JO - Arab J Gastroenterol VL - 13 UR - https://doi.org/10.1016/j.ajg.2012.06.004 DO - 10.1016/j.ajg.2012.06.004 ID - Kobeisy2012 ER - TY - JOUR AU - Fattovich, G. AU - Giustina, G. AU - Degos, F. AU - Tremolada, F. AU - Diodati, G. AU - Almasio, P. PY - 1997 DA - 1997// TI - Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients JO - Gastroenterology VL - 112 UR - https://doi.org/10.1053/gast.1997.v112.pm9024300 DO - 10.1053/gast.1997.v112.pm9024300 ID - Fattovich1997 ER - TY - JOUR AU - Sato, Y. AU - Nakata, K. AU - Kato, Y. AU - Shima, M. AU - Ishii, N. AU - Koji, T. PY - 1993 DA - 1993// TI - Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein JO - N Engl J Med VL - 328 UR - https://doi.org/10.1056/NEJM199306243282502 DO - 10.1056/NEJM199306243282502 ID - Sato1993 ER - TY - JOUR AU - Tong, M. J. AU - Farra, N. S. AU - Reikes, A. R. AU - Co, R. L. PY - 1995 DA - 1995// TI - Clinical outcomes after transfusionassociated hepatitis C JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199506013322202 DO - 10.1056/NEJM199506013322202 ID - Tong1995 ER - TY - JOUR AU - Aguayo, A. AU - Patt, Y. Z. PY - 2001 DA - 2001// TI - Liver cancer JO - Clin Liver Dis VL - 5 UR - https://doi.org/10.1016/S1089-3261(05)70175-6 DO - 10.1016/S1089-3261(05)70175-6 ID - Aguayo2001 ER - TY - JOUR AU - Chang, T. S. AU - Wu, Y. C. AU - Tung, S. Y. AU - Wei, K. L. AU - Hsieh, Y. Y. AU - Huang, H. C. PY - 2015 DA - 2015// TI - Alpha-fetoprotein measurement benefits hepatocellular carcinoma surveillance in patients with cirrhosis JO - Am J Gastroenterol VL - 110 UR - https://doi.org/10.1038/ajg.2015.100 DO - 10.1038/ajg.2015.100 ID - Chang2015 ER - TY - JOUR AU - Singal, A. AU - Volk, M. L. AU - Waljee, A. AU - Salgia, R. AU - Higgins, P. AU - Rogers, M. A. PY - 2009 DA - 2009// TI - Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis JO - Aliment Pharm Ther VL - 30 UR - https://doi.org/10.1111/j.1365-2036.2009.04014.x DO - 10.1111/j.1365-2036.2009.04014.x ID - Singal2009 ER - TY - JOUR AU - Grizzi, F. AU - Colombo, P. AU - Taverna, G. AU - Chiriva-Internati, M. AU - Cobos, E. AU - Graziotti, P. PY - 2007 DA - 2007// TI - Geometry of human vascular system: is it an obstacle for quantifying antiangiogenic therapies? JO - Appl Immunohisto M M VL - 15 UR - https://doi.org/10.1097/01.pai.0000213105.18569.fa DO - 10.1097/01.pai.0000213105.18569.fa ID - Grizzi2007 ER - TY - JOUR AU - Harada, T. AU - Shigeta, K. AU - Noda, K. AU - Fukumoto, Y. AU - Nishimura, H. AU - Mizuta, M. PY - 1980 DA - 1980// TI - Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study JO - Hepato-gastroenterology VL - 27 ID - Harada1980 ER - TY - JOUR AU - Johnson, P. J. PY - 2001 DA - 2001// TI - The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma JO - Clin Liver Dis VL - 5 UR - https://doi.org/10.1016/S1089-3261(05)70158-6 DO - 10.1016/S1089-3261(05)70158-6 ID - Johnson2001 ER - TY - JOUR AU - Lu, Y. AU - Zhu, M. AU - Li, W. AU - Lin, B. AU - Dong, X. AU - Chen, Y. AU - Xie, X. AU - Guo, J. AU - Li, M. PY - 2016 DA - 2016// TI - Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells JO - J Cell Mol Med VL - 20 UR - https://doi.org/10.1111/jcmm.12745 DO - 10.1111/jcmm.12745 ID - Lu2016 ER - TY - JOUR AU - Singal, A. G. AU - Conjeevaram, H. S. AU - Volk, M. L. AU - Fu, S. AU - Fontana, R. J. AU - Askari, F. PY - 2012 DA - 2012// TI - Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis JO - Cancer Epidemiol Biomark Prev VL - 21 UR - https://doi.org/10.1158/1055-9965.EPI-11-1005 DO - 10.1158/1055-9965.EPI-11-1005 ID - Singal2012 ER -